TY - JOUR
T1 - Hemolytic Anemia in Pregnancy
T2 - A Rare and Challenging Case in Indonesia
AU - Hasanah, Miftah
AU - Hernaningsih, Yetti
N1 - Funding Information:
Miftah Hasanah, M.D., contributed to data collection, performed laboratory examinations, obtained images, drafted the case report, and revised the manuscript and Dr. Yetti Hernaningsih, M.D., Clinical Pathologist, provided expertise in hematology and contributed to the revision of the paper.
Publisher Copyright:
© 2023 The Author(s).
PY - 2023/11
Y1 - 2023/11
N2 - Autoimmune hemolytic anemia (AIHA) is an infrequent etiology of anemia during pregnancy, and its occurrence in the postpartum period is even more uncommon. This study presents the case of a 27-year-old woman who exhibited severe anemia and thrombocytopenia six weeks after delivery. Hemolysis was confirmed upon evaluation, and a diagnosis of AIHA was established based on a positive direct antiglobulin test (DAT) and the presence of autoantibodies targeting red blood cells (RBCs). Treatment with steroids resulted in an improvement in the patient's hemoglobin levels. The demographic characteristics observed in our case align with prior research, which has documented mild anemia during pregnancy, lower gestational age, and decreased fetal birth weight in primary AIHA cases. Furthermore, thrombocytopenia can be manifested in AIHA during pregnancy, necessitating long-term monitoring of such patients. The AIHA rarity as a causative factor for anemia during pregnancy, particularly in the postpartum period, underscores the significance of including AIHA in the differential diagnosis for severe anemia. Moreover, extended follow-up care is essential for managing these patients. Employing a multidisciplinary approach to prenatal care facilitates the identification and management of rare complications, such as AIHA.
AB - Autoimmune hemolytic anemia (AIHA) is an infrequent etiology of anemia during pregnancy, and its occurrence in the postpartum period is even more uncommon. This study presents the case of a 27-year-old woman who exhibited severe anemia and thrombocytopenia six weeks after delivery. Hemolysis was confirmed upon evaluation, and a diagnosis of AIHA was established based on a positive direct antiglobulin test (DAT) and the presence of autoantibodies targeting red blood cells (RBCs). Treatment with steroids resulted in an improvement in the patient's hemoglobin levels. The demographic characteristics observed in our case align with prior research, which has documented mild anemia during pregnancy, lower gestational age, and decreased fetal birth weight in primary AIHA cases. Furthermore, thrombocytopenia can be manifested in AIHA during pregnancy, necessitating long-term monitoring of such patients. The AIHA rarity as a causative factor for anemia during pregnancy, particularly in the postpartum period, underscores the significance of including AIHA in the differential diagnosis for severe anemia. Moreover, extended follow-up care is essential for managing these patients. Employing a multidisciplinary approach to prenatal care facilitates the identification and management of rare complications, such as AIHA.
KW - AIHA
KW - Anemia
KW - Case report
KW - Hematology
KW - Maternal medicine
KW - Pregnancy
KW - Thrombocytopenia
UR - http://www.scopus.com/inward/record.url?scp=85167796392&partnerID=8YFLogxK
U2 - 10.26655/JMCHEMSCI.2023.11.12
DO - 10.26655/JMCHEMSCI.2023.11.12
M3 - Article
AN - SCOPUS:85167796392
SN - 2651-4702
SP - 2679
EP - 2685
JO - Journal of Medicinal and Chemical Sciences
JF - Journal of Medicinal and Chemical Sciences
IS - 6
ER -